Bausch Health
BHC
6.15
+0.13
+2.16%
Bausch Health
US · BHC
#2722 by market cap
Listed 1970
6.15
+0.13
+2.16%
Live - 5344 symbols - heartbeat 53s ago
· 2026-10-08 06:55
Pre-market
5.60
-8.92%
After-hours
6.15
0.00%
- Market cap
- 2.30B
- P/E (TTM)i
- -2.09
- P/Bi
- -1.30
- EPSi
- 0.42
- Div yieldi
- 0.00%
- 52W posi
- 50%
Reader sentiment
Are you bullish or bearish on BHC?
Anonymous reader poll. Unscientific, not investment advice.
Recent news
-
Barclays Maintains Bausch Health(BHC.US) With Hold Rating, Maintains Target Price $7Market Newswire · 2026/6/4
-
Rating change
Truist Financial Maintains Bausch Health(BHC.US) With Hold Rating, Announces Target Price $6.78Market Newswire · 2025/7/25
-
Rating change
TD Cowen Maintains Bausch Health(BHC.US) With Hold Rating, Maintains Target Price $7Market Newswire · 2026/2/21
-
Rating change
Truist Financial Maintains Bausch Health(BHC.US) With Hold Rating, Announces Target Price $8Market Newswire · 2026/1/7
-
Rating change
Analysts Have Conflicting Sentiments on These Healthcare Companies: Chemed (CHE), Bausch Health Companies (BHC) and CG Oncology, Inc. (CGON)TipRanks · 2026/4/27
-
Company notice
MCOM: Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - BHC HOLDINGS SDN. BHD.Bursa Malaysia · 2026/6/5
-
Rating change
Raymond James Maintains Bausch Health(BHC.US) With Hold Rating, Maintains Target Price $8Market Newswire · 2025/8/5
-
Rating change
RBC Capital Maintains Bausch Health(BHC.US) With Hold Rating, Maintains Target Price $10Market Newswire · 2026/2/19
-
RBC Capital Maintains Bausch Health(BHC.US) With Hold Rating, Cuts Target Price to $9Market Newswire · 2026/4/27
-
Rating change
Analysts Conflicted on These Healthcare Names: Bausch Health Companies (BHC), Thermo Fisher (TMO) and Mineralys Therapeutics, Inc. (MLYS)TipRanks · 2025/10/30
-
Rating change
BofA Securities Maintains Bausch Health(BHC.US) With Sell Rating, Maintains Target Price $5Market Newswire · 2026/2/19
-
Rating change
Truist Financial Maintains Bausch Health(BHC.US) With Hold RatingMarket Newswire · 2026/2/19
-
Rating change
Truist Financial Initiates Bausch Health(BHC.US) With Hold RatingMarket Newswire · 2025/7/30
-
Rating change
Truist Financial Maintains Bausch Health(BHC.US) With Hold Rating, Maintains Target Price $8Market Newswire · 2026/1/24
-
RBC Capital Maintains Bausch Health(BHC.US) With Hold Rating, Maintains Target Price $9Market Newswire · 2026/7/31
-
A Quick Look at Today's Ratings for Bausch Health(BHC.US), With a Forecast Between $7 to $9Market Newswire · 2026/5/1
-
Rating change
TR | OpenAI - 4o Maintains Bausch Health(BHC.US) With Hold Rating, Cuts Target Price to $5.81Market Newswire · 2025/8/11
-
Earnings Call Summary | Bausch Health(BHC.US) Q1 2026 Earnings ConferenceMarket Newswire · 2026/4/30
-
Rating change
Barclays Maintains Bausch Health(BHC.US) With Hold Rating, Cuts Target Price to $7Market Newswire · 2026/2/25
-
Rating change
Analysts Offer Insights on Healthcare Companies: Heart Test Laboratories, Inc. (HSCS) and Bausch Health Companies (BHC)TipRanks · 2025/7/29
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-10-08 06:55:45 · For reference only, not investment advice and not tailored to your situation.